|
|
Article: Esophagitis due to tetracycline and its derivatives in dermatology patients.
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- March 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abstract
Medication induced esophagitis (MIE) has been reported in dermatology patients taking tetracycline antibiotics. The symptoms of esophagitis, preventable with proper instruction, can create morbidity and lead to increased costs for patients. Our study sought to quantify the incidence of MIE in patients taking tetracycline antibiotics and to investigate how these patients develop MIE. A cross-sectional questionnaire survey was given at outpatient dermatology clinics. Ninety-three surveys from patients who had taken tetracycline antibiotics and 48 surveys from a control group were analyzed. Incidence of esophagitis symptoms (difficulty or pain with ...
Related newspaper, magazine, and journal articles:
|
|
Article: CollaGenex Pharmaceuticals Announces Publication of an ...
Business Wire;
July 14, 2003 ;
700+ words
... ... label, 50-patient study was designed ... telangiectatic vessels. Patients were treated ... weeks treatment, patients experienced an ... higher doses of tetracycline antibiotics. "This study ... higher doses of tetracycline antibiotics without the associated ... option for rosacea ...
|
|